Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1997 Apr;60(4):935–947.

PCR-based screening for cystic fibrosis carrier mutations in an ethnically diverse pregnant population.

W W Grody 1, C Dunkel-Schetter 1, Z H Tatsugawa 1, M A Fox 1, C Y Fang 1, R M Cantor 1, J M Novak 1, H N Bass 1, B F Crandall 1
PMCID: PMC1712478  PMID: 9106541

Abstract

As the most common lethal autosomal recessive disorder in North America, cystic fibrosis (CF) is an obvious candidate for general population carrier screening. Although the identification of the causative gene has made detection of asymptomatic carriers possible, the extreme heterogeneity of its mutations has limited the sensitivity of the available DNA screening tests and has called into question their utility when they are applied to patients with no family history of the disease. The purpose of this study was to determine the technical feasibility, patient acceptance and understanding, and psychosocial impact of large-scale CF carrier screening in an ethnically diverse pregnant population. A total of 4,739 pregnant women attending prenatal clinics located in both an academic medical center and a large HMO were invited in person to participate. Of this group, 3,543 received CF instruction and assessments of knowledge and mood, and 3,192 underwent DNA testing for the six most common CF mutations, by means of a noninvasive PCR-based reverse-dot-blot method. Overall participation rates (ranging from 53% at the HMO to 77% at the academic center) and consent rates for DNA testing after CF instruction (>98%) exceeded those of most other American studies. The PCR-based screening method worked efficiently on large numbers of samples, and 55 carriers and one at-risk couple were identified. Understanding of residual risk, anxiety levels, and overall satisfaction with the program were acceptable across all ethnic groups. Our strategy of approaching a motivated pregnant population in person with a rapid and noninvasive testing method may provide a practical model for developing a larger CF screening program targeting appropriate high-risk groups at the national level, and may also serve as a paradigm for population-based screening of other genetically heterogeneous disorders in the future.

Full text

PDF
935

Images in this article

938Figure 1
on p.938

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asch D. A., Patton J. P., Hershey J. C., Mennuti M. T. Reporting the results of cystic fibrosis carrier screening. Am J Obstet Gynecol. 1993 Jan;168(1 Pt 1):1–6. doi: 10.1016/s0002-9378(12)90875-3. [DOI] [PubMed] [Google Scholar]
  2. Beaudet A. L. Carrier screening for cystic fibrosis. Am J Hum Genet. 1990 Oct;47(4):603–605. [PMC free article] [PubMed] [Google Scholar]
  3. Bekker H., Denniss G., Modell M., Bobrow M., Marteau T. The impact of population based screening for carriers of cystic fibrosis. J Med Genet. 1994 May;31(5):364–368. doi: 10.1136/jmg.31.5.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Biesecker L., Bowles-Biesecker B., Collins F., Kaback M., Wilfond B. General population screening for cystic fibrosis is premature. Am J Hum Genet. 1992 Feb;50(2):438–439. [PMC free article] [PubMed] [Google Scholar]
  5. Billings P. R., Kohn M. A., de Cuevas M., Beckwith J., Alper J. S., Natowicz M. R. Discrimination as a consequence of genetic testing. Am J Hum Genet. 1992 Mar;50(3):476–482. [PMC free article] [PubMed] [Google Scholar]
  6. Blitzer M. G., McDowell G. A. Tay-Sachs disease as a model for screening inborn errors. Clin Lab Med. 1992 Sep;12(3):463–480. [PubMed] [Google Scholar]
  7. Brock D. Population screening for cystic fibrosis. Am J Hum Genet. 1990 Jul;47(1):164–165. [PMC free article] [PubMed] [Google Scholar]
  8. Caskey C. T., Kaback M. M., Beaudet A. L. The American Society of Human Genetics statement on cystic fibrosis screening. Am J Hum Genet. 1990 Feb;46(2):393–393. [PMC free article] [PubMed] [Google Scholar]
  9. Chapple J. C., Dale R., Evans B. G. The new genetics: will it pay its way? Lancet. 1987 May 23;1(8543):1189–1192. doi: 10.1016/s0140-6736(87)92153-2. [DOI] [PubMed] [Google Scholar]
  10. Chehab F. F., Wall J. Detection of multiple cystic fibrosis mutations by reverse dot blot hybridization: a technology for carrier screening. Hum Genet. 1992 May;89(2):163–168. doi: 10.1007/BF00217117. [DOI] [PubMed] [Google Scholar]
  11. Childs B., Gordis L., Kaback M. M., Kazazian H. H., Jr Tay-Sachs screening: motives for participating and knowledge of genetics and probability. Am J Hum Genet. 1976 Nov;28(6):537–549. [PMC free article] [PubMed] [Google Scholar]
  12. Clayton E. W., Hannig V. L., Pfotenhauer J. P., Parker R. A., Campbell P. W., 3rd, Phillips J. A., 3rd Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. Am J Hum Genet. 1996 Mar;58(3):617–627. [PMC free article] [PubMed] [Google Scholar]
  13. Crystal R. G., McElvaney N. G., Rosenfeld M. A., Chu C. S., Mastrangeli A., Hay J. G., Brody S. L., Jaffe H. A., Eissa N. T., Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet. 1994 Sep;8(1):42–51. doi: 10.1038/ng0994-42. [DOI] [PubMed] [Google Scholar]
  14. Curtis A., Richardson R. J., Boohene J., Jackson A., Nelson R., Bhattacharya S. S. Absence of cystic fibrosis mutations in a large Asian population sample and occurrence of a homozygous S549N mutation in an inbred Pakistani family. J Med Genet. 1993 Feb;30(2):164–166. doi: 10.1136/jmg.30.2.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cutting G. R., Curristin S. M., Nash E., Rosenstein B. J., Lerer I., Abeliovich D., Hill A., Graham C. Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians. Am J Hum Genet. 1992 Jun;50(6):1185–1194. [PMC free article] [PubMed] [Google Scholar]
  16. DeMarchi J. M., Beaudet A. L., Caskey C. T., Richards C. S. Experience of an academic reference laboratory using automation for analysis of cystic fibrosis mutations. Arch Pathol Lab Med. 1994 Jan;118(1):26–32. [PubMed] [Google Scholar]
  17. Gilbert F. Is population screening for cystic fibrosis appropriate now? Am J Hum Genet. 1990 Feb;46(2):394–395. [PMC free article] [PubMed] [Google Scholar]
  18. Gostin L. Genetic discrimination: the use of genetically based diagnostic and prognostic tests by employers and insurers. Am J Law Med. 1991;17(1-2):109–144. [PubMed] [Google Scholar]
  19. Grebe T. A., Doane W. W., Richter S. F., Clericuzio C., Norman R. A., Seltzer W. K., Rhodes S. N., Goldberg B. E., Hernried L. S., McClure M. Mutation analysis of the cystic fibrosis transmembrane regulator gene in Native American populations of the southwest. Am J Hum Genet. 1992 Oct;51(4):736–740. [PMC free article] [PubMed] [Google Scholar]
  20. Grebe T. A., Seltzer W. K., DeMarchi J., Silva D. K., Doane W. W., Gozal D., Richter S. F., Bowman C. M., Norman R. A., Rhodes S. N. Genetic analysis of Hispanic individuals with cystic fibrosis. Am J Hum Genet. 1994 Mar;54(3):443–446. [PMC free article] [PubMed] [Google Scholar]
  21. Harris H., Scotcher D., Hartley N., Wallace A., Craufurd D., Harris R. Cystic fibrosis carrier testing in early pregnancy by general practitioners. BMJ. 1993 Jun 12;306(6892):1580–1583. doi: 10.1136/bmj.306.6892.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hubbard R. C., McElvaney N. G., Birrer P., Shak S., Robinson W. W., Jolley C., Wu M., Chernick M. S., Crystal R. G. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med. 1992 Mar 19;326(12):812–815. doi: 10.1056/NEJM199203193261207. [DOI] [PubMed] [Google Scholar]
  23. Jung U., Urner U., Grade K., Coutelle C. Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population. Hum Genet. 1994 Jul;94(1):19–24. doi: 10.1007/BF02272835. [DOI] [PubMed] [Google Scholar]
  24. Kerem B., Rommens J. M., Buchanan J. A., Markiewicz D., Cox T. K., Chakravarti A., Buchwald M., Tsui L. C. Identification of the cystic fibrosis gene: genetic analysis. Science. 1989 Sep 8;245(4922):1073–1080. doi: 10.1126/science.2570460. [DOI] [PubMed] [Google Scholar]
  25. Kerem E., Lynch A. Screening for cystic fibrosis. Ethical and social issues. Am Rev Respir Dis. 1991 Mar;143(3):457–460. doi: 10.1164/ajrccm/143.3.457. [DOI] [PubMed] [Google Scholar]
  26. Knowles M. R., Hohneker K. W., Zhou Z., Olsen J. C., Noah T. L., Hu P. C., Leigh M. W., Engelhardt J. F., Edwards L. J., Jones K. R. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med. 1995 Sep 28;333(13):823–831. doi: 10.1056/NEJM199509283331302. [DOI] [PubMed] [Google Scholar]
  27. Livingstone J., Axton R. A., Gilfillan A., Mennie M., Compton M., Liston W. A., Calder A. A., Gordon A. J., Brock D. J. Antenatal screening for cystic fibrosis: a trial of the couple model. BMJ. 1994 Jun 4;308(6942):1459–1462. doi: 10.1136/bmj.308.6942.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Loader S., Caldwell P., Kozyra A., Levenkron J. C., Boehm C. D., Kazazian H. H., Jr, Rowley P. T. Cystic fibrosis carrier population screening in the primary care setting. Am J Hum Genet. 1996 Jul;59(1):234–247. [PMC free article] [PubMed] [Google Scholar]
  29. Loader S., Sutera C. J., Walden M., Kozyra A., Rowley P. T. Prenatal screening for hemoglobinopathies. II. Evaluation of counseling. Am J Hum Genet. 1991 Mar;48(3):447–451. [PMC free article] [PubMed] [Google Scholar]
  30. McCrae W. M., Cull A. M., Burton L., Dodge J. Cystic fibrosis: parents' response to the genetic basis of the disease. Lancet. 1973 Jul 21;2(7821):141–143. doi: 10.1016/s0140-6736(73)93078-x. [DOI] [PubMed] [Google Scholar]
  31. Mennie M. E., Compton M. E., Gilfillan A., Liston W. A., Pullen I., Whyte D. A., Brock D. J. Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners. J Med Genet. 1993 Jul;30(7):543–548. doi: 10.1136/jmg.30.7.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mennie M. E., Gilfillan A., Compton M. E., Liston W. A., Brock D. J. Prenatal cystic fibrosis carrier screening: factors in a woman's decision to decline testing. Prenat Diagn. 1993 Sep;13(9):807–814. doi: 10.1002/pd.1970130904. [DOI] [PubMed] [Google Scholar]
  33. Mennie M. E., Gilfillan A., Compton M., Curtis L., Liston W. A., Pullen I., Whyte D. A., Brock D. J. Prenatal screening for cystic fibrosis. Lancet. 1992 Jul 25;340(8813):214–216. doi: 10.1016/0140-6736(92)90476-j. [DOI] [PubMed] [Google Scholar]
  34. Miedzybrodzka Z. H., Hall M. H., Mollison J., Templeton A., Russell I. T., Dean J. C., Kelly K. F., Marteau T. M., Haites N. E. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening. BMJ. 1995 Feb 11;310(6976):353–357. doi: 10.1136/bmj.310.6976.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Richards B., Skoletsky J., Shuber A. P., Balfour R., Stern R. C., Dorkin H. L., Parad R. B., Witt D., Klinger K. W. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet. 1993 Feb;2(2):159–163. doi: 10.1093/hmg/2.2.159. [DOI] [PubMed] [Google Scholar]
  36. Riordan J. R., Rommens J. M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J. L. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989 Sep 8;245(4922):1066–1073. doi: 10.1126/science.2475911. [DOI] [PubMed] [Google Scholar]
  37. Rommens J. M., Iannuzzi M. C., Kerem B., Drumm M. L., Melmer G., Dean M., Rozmahel R., Cole J. L., Kennedy D., Hidaka N. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989 Sep 8;245(4922):1059–1065. doi: 10.1126/science.2772657. [DOI] [PubMed] [Google Scholar]
  38. Rosenfeld M. A., Yoshimura K., Trapnell B. C., Yoneyama K., Rosenthal E. R., Dalemans W., Fukayama M., Bargon J., Stier L. E., Stratford-Perricaudet L. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 1992 Jan 10;68(1):143–155. doi: 10.1016/0092-8674(92)90213-v. [DOI] [PubMed] [Google Scholar]
  39. Rosenstock I. M. Why people use health services. Milbank Mem Fund Q. 1966 Jul;44(3 Suppl):94–127. [PubMed] [Google Scholar]
  40. Schulman J. D., Maddalena A., Black S. H., Bick D. P. Screening for cystic fibrosis carriers. Am J Hum Genet. 1990 Oct;47(4):740–740. [PMC free article] [PubMed] [Google Scholar]
  41. Shuber A. P., Skoletsky J., Stern R., Handelin B. L. Efficient 12-mutation testing in the CFTR gene: a general model for complex mutation analysis. Hum Mol Genet. 1993 Feb;2(2):153–158. doi: 10.1093/hmg/2.2.153. [DOI] [PubMed] [Google Scholar]
  42. Snouwaert J. N., Brigman K. K., Latour A. M., Malouf N. N., Boucher R. C., Smithies O., Koller B. H. An animal model for cystic fibrosis made by gene targeting. Science. 1992 Aug 21;257(5073):1083–1088. doi: 10.1126/science.257.5073.1083. [DOI] [PubMed] [Google Scholar]
  43. Tambor E. S., Bernhardt B. A., Chase G. A., Faden R. R., Geller G., Hofman K. J., Holtzman N. A. Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. Am J Hum Genet. 1994 Oct;55(4):626–637. [PMC free article] [PubMed] [Google Scholar]
  44. Thomson D. M., Brown N. N., Clague A. E. Routine use of hair root or buccal swab specimens for PCR analysis: advantages over using blood. Clin Chim Acta. 1992 May 15;207(3):169–174. doi: 10.1016/0009-8981(92)90116-8. [DOI] [PubMed] [Google Scholar]
  45. Wald N. J. Couple screening for cystic fibrosis. Lancet. 1991 Nov 23;338(8778):1318–1319. doi: 10.1016/0140-6736(91)92605-2. [DOI] [PubMed] [Google Scholar]
  46. Wall J., Cai S., Chehab F. F. A 31-mutation assay for cystic fibrosis testing in the clinical molecular diagnostics laboratory. Hum Mutat. 1995;5(4):333–338. doi: 10.1002/humu.1380050411. [DOI] [PubMed] [Google Scholar]
  47. Walsh P. S., Metzger D. A., Higuchi R. Chelex 100 as a medium for simple extraction of DNA for PCR-based typing from forensic material. Biotechniques. 1991 Apr;10(4):506–513. [PubMed] [Google Scholar]
  48. Watson E. K., Mayall E. S., Lamb J., Chapple J., Williamson R. Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet. 1992 Jul 25;340(8813):217–220. doi: 10.1016/0140-6736(92)90477-k. [DOI] [PubMed] [Google Scholar]
  49. Watson E. K., Mayall E., Chapple J., Dalziel M., Harrington K., Williams C., Williamson R. Screening for carriers of cystic fibrosis through primary health care services. BMJ. 1991 Aug 31;303(6801):504–507. doi: 10.1136/bmj.303.6801.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Weil J. Mothers' postcounseling beliefs about the causes of their children's genetic disorders. Am J Hum Genet. 1991 Jan;48(1):145–153. [PMC free article] [PubMed] [Google Scholar]
  51. Whitten C. F. Sickle-cell programming--an imperiled promise. N Engl J Med. 1973 Feb 8;288(6):318–319. doi: 10.1056/NEJM197302082880612. [DOI] [PubMed] [Google Scholar]
  52. Whitten C. F., Thomas J. F., Nishiura E. N. Sickle cell trait counseling-evaluation of counselors and counselees. Am J Hum Genet. 1981 Sep;33(5):802–816. [PMC free article] [PubMed] [Google Scholar]
  53. Wilfond Benjamin S., Fost Norman. The cystic fibrosis gene: medical and social implications for heterozygote detection. JAMA. 1990 May 23;263(10):2777–2783. [PubMed] [Google Scholar]
  54. Williamson R. Universal community carrier screening for cystic fibrosis? Nat Genet. 1993 Mar;3(3):195–201. doi: 10.1038/ng0393-195. [DOI] [PubMed] [Google Scholar]
  55. Witt D. R., Schaefer C., Hallam P., Wi S., Blumberg B., Fishbach A., Holtzman J., Kornfeld S., Lee R., Nemzer L. Cystic fibrosis heterozygote screening in 5,161 pregnant women. Am J Hum Genet. 1996 Apr;58(4):823–835. [PMC free article] [PubMed] [Google Scholar]
  56. Yuen J., Hsia Y. E., Hall J. Thalassemia heterozygotes in Hawaii: ethnic attitudes toward screening and prenatal diagnosis. Hemoglobin. 1988;12(5-6):801–816. doi: 10.3109/03630268808991673. [DOI] [PubMed] [Google Scholar]
  57. Zeesman S., Clow C. L., Cartier L., Scriver C. R. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal. Am J Med Genet. 1984 Aug;18(4):769–778. doi: 10.1002/ajmg.1320180424. [DOI] [PubMed] [Google Scholar]
  58. ten Kate L. P. Carrier screening for cystic fibrosis and other autosomal recessive diseases. Am J Hum Genet. 1990 Aug;47(2):359–361. [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES